UK markets closed

Novozymes A/S (NVZMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
48.05+1.00 (+2.13%)
At close: 09:30AM EDT
Show:
Annual

Income statement

Currency in DKK. All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
16,252,000
14,951,000
14,012,000
14,374,000
14,390,000
Cost of revenue
7,120,000
6,328,000
6,159,000
6,420,000
6,135,000
Gross profit
9,132,000
8,623,000
7,853,000
7,954,000
8,255,000
Operating expenses
Research development
1,938,000
2,009,000
1,937,000
1,966,000
1,865,000
Selling general and administrative
3,121,000
2,795,000
2,320,000
2,469,000
2,363,000
Total operating expenses
5,102,000
4,738,000
4,243,000
4,409,000
4,185,000
Operating income or loss
4,030,000
3,885,000
3,610,000
3,545,000
4,070,000
Interest expense
-
102,000
63,000
86,000
13,000
Income before tax
3,948,000
3,924,000
3,521,000
3,799,000
3,936,000
Income tax expense
826,000
779,000
695,000
644,000
709,000
Income from continuing operations
3,122,000
3,145,000
2,826,000
3,155,000
3,227,000
Net income
3,108,000
3,146,000
2,825,000
3,154,000
3,226,000
Net income available to common shareholders
3,108,000
3,146,000
2,825,000
3,154,000
3,226,000
Basic EPS
-
11.32
10.07
11.06
11.11
Diluted EPS
-
11.23
10.02
11.01
11.03
Basic average shares
-
277,919
280,428
285,110
290,422
Diluted average shares
-
280,228
282,023
286,551
292,362
EBITDA
-
5,442,000
4,850,000
5,067,000
4,960,000